Press Release: Recombinetics : Makana Therapeutics Announces the Appointment of Dr. Kurt Dasse to Its Board of Directors
EAGAN, Minn., Aug. 11, 2021 /PRNewswire/ -- Makana Therapeutics, a subsidiary of Recombinetics Inc., a leading gene editing company with platform technology applied to biomedicine and animal agriculture, announced today the appointment of Kurt A. Dasse, Ph.D., to its Board of Directors....
Read full article »
Recombinetics is a Minnesota-based biotech firm that offers animal gene editing and gene repairing services in sectors including biomedical research and regenerative medicine.
Read more